Insiders Buy More Than $210M Of 3 Stocks
Although U.S. stock futures traded lower this morning on Tuesday, there were a few notable insider trades.
Liquidia Shares Slide On Proposed Public Offering
Liquidia Corp (NASDAQ: LQDA) has commenced an underwritten public offering of its common stock. All of the shares are to be sold by the company.
The Daily Biotech Pulse: AbbVie’s Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Preview: Liquidia Technologies’s Earnings
Liquidia Technologies (NASDAQ:LQDA) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.
Analysts estimate that Liquidia Technologies will report an earnings per share (EPS) of $-0.11.
HC Wainwright & Co. Maintains Buy on Liquidia, Raises Price Target to $16
HC Wainwright & Co. analyst Andrew Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $6 to $16.
Needham Maintains Buy on Liquidia, Raises Price Target to $12
Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $8 to $12.
Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40M
Liquidia Corporation (NASDAQ:LQDA) announced today the closing of a debt facility on January 7, 2022, with Silicon Valley Bank (SVB) which provides Liquidia with up to $40.0 million in term loans of which the
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours: